1027587-99-0

Upstream product

• 1011-27-4 3,5-dimethoxy-4-methylbenzaldehyde 
• 81418-49-7 5-(benzyloxy)-2-bromobenzaldehyde dimethylacetal 
• 212501-50-3 (4-benzyloxy-2-dimethoxymethyl-phenyl)-(3,5-dimethoxy-4-methyl-phenyl)-methanone 

Downstream Products

• 212501-60-5 7-benzyloxy-4-(4-methyl-3,5-trimethoxyphenyl)-3-isocoumarincarboxylic acid 
• 212501-68-3 7-benzyloxy-4-(3,5-dimethoxy-4-methyl-phenyl)-3-hydroxy-1-oxo-isochroman-3-carboxylic acid 
• 212499-73-5 2-(4-tert-butoxycarbonylamino-phenyl)-4-(3,5-dimethoxy-4-methyl-phenyl)-7-hydroxy-1-oxo-1,2-dihydro-isoquinoline-3-carboxylic acid methyl ester 
• 212499-67-7 methyl 7-benzyloxy-2-[(4-tert-butoxycarbonylamino)phenyl]-4-(3,4-dimethoxy-4-methylphenyl)-1,2-dihydro-1-oxo-3-isoquinolinecarboxylate 
• 212501-55-8 3-benzyloxy-6-(4-methyl-3,5-dimethoxybenzoyl)benzoic acid 

Relevant academic research and scientific papers

Novel, potent, and selective phosphodiesterase 5 inhibitors: Synthesis and biological activities of a series of 4-aryl-1-isoquinolinone derivatives

A novel class of potent and selective phosphodiesterase 5 (PDE5) inhibitors, 4-aryl-1-isoquinolinone derivatives, which have been designed by the comparison of the structure of cGMP and a previously reported 1-arylnaphthalene lignan, was disclosed. Among